High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

Annals of Oncology

Volumn 12, Issue 3, 2001, Pages 353-356

  Crivellari, D ^a   Pagani, O ^b   Veronesi, A ^a   Lombardi, D ^a   Nole F ^c   Thurlimann B ^d   Hess, D ^d   Borner, M ^e   Bauer, J ^f   Martinelli, G ^c   Graffeo, R ^b   Sessa, C ^b   Goldhirsch, A ^c  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Breast cancer; Central nervous system involvement; Taxotere

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CIMETIDINE; DEXAMETHASONE; DOCETAXEL; EPIRUBICIN; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASSAY; BRAIN CORTEX; BRAIN METASTASIS; BREAST CANCER; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER SURVIVAL; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE OVEREXPRESSION; HUMAN; LEPTOMENINX; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; ONCOGENE C ERB; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0035071938     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011132609055     Document Type: Article

References (18)

1. The natural history of breast cancer patients with brain metastases
2. Central nervous system metastases from breast carcinoma: Autopsy study
3. Chemotherapy induces regression of brain metastases in breast carcinoma
4. Response of brain metastases from breast cancer to systemic chemotherapy
5. Phase I study of Docetaxel and Epirubicin in advanced breast cancer
6. Docetaxel (D) in combination with Epirubicin (E) as first-line therapy for metastatic breast cancer (MBC): Final results
7. First-line epirubicin (EPI) and Taxotere (TXT) in advanced breast cancer: A phase I study
8. Dose-finding study of Epidoxorubicin and Docetaxel as first-line chemotherapy in patients with advanced breast cancer
9. Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study
10. Reporting results of cancer treatment
11. Intracranial metastases from systemic cancer
12. Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer
13. Adjuvant therapy with 5-fluorouracil, adriamycin, cyclophosphamide and BCG (FAC-BCG) for stage II or III breast cancer
14. Brain metastases in breast cancer patients receiving adjuvant chemotherapy
15. The biology and mechanism of chemoresistance of brain metastases
16. Distribution of 3H-Taxol in the nervous system (NS) and organs of rats
17. Central nervous system progression of metastatic breast cancer in patients treated with Paclitaxel
18. Hydrocortisone activation of human Herpesvirus 8 viral DNA replication and gene expression in vitro